March 27, 2015
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
- /
CAMBRIDGE, Mass. & NORTH CHICAGO, Ill.–(BUSINESS WIRE)– Today Biogen (BIIB) and AbbVie (ABBV) announced that the European Medicines Agency (EMA) has validated the companies’ Marketing…
